Pentwater Capital Management LP Provention Bio, Inc. Transaction History

Pentwater Capital Management LP

  • $9.58 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$6.7 - $24.21 $21 Million - $75.9 Million
3,135,000 New
3,135,000 $75.6 Million
Q2 2021

Aug 16, 2021
SELL
$6.71 - $11.04 $67,100 - $110,399
-10,000 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$10.12 - $19.45 $101,199 - $194,500
10,000 New
10,000 $105,000
Q4 2019

Feb 14, 2020
SELL
$5.84 - $14.9 $116,800 - $298,000
-20,000 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$6.83 - $13.0 $136,600 - $260,000
20,000 New
20,000 $137,000

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0
View Full List

About Provention Bio, Inc.

PRVB Quotes by TradingView
  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track Pentwater Capital Management LP Portfolio

Follow Pentwater Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Pentwater Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email